- OMER Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
CORRESP Filing
Omeros (OMER) CORRESPCorrespondence with SEC
Filed: 5 Oct 09, 12:00am
Attention: | Mr. Jeffrey Riedler Ms. Rose Zukin |
Re: | Omeros Corporation (the “Company”) Registration Statement on Form S-1, as amended (File No. 333-148572) (the “Registration Statement”) |
ACCELERATION REQUEST | ||
REQUESTED DATE: | OCTOBER 7, 2009 | |
REQUESTED TIME: | 4:00 PM EASTERN TIME |
• | should the Commission or the Staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing; | ||
• | the action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and | ||
• | the Company may not assert the action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the Registration Statement effective as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. |
Sincerely, OMEROS CORPORATION | ||||
By: | /s/ Gregory A. Demopulos, M.D. | |||
Gregory A. Demopulos, M.D. | ||||
President, Chief Executive Officer, Chief Medical Officer and Chairman of the Board of Directors | ||||